MARKETVOLUME®

www.MarketVolume.com

CURIS (Stock Symbol: CRIS)

CRIS- Stock Profile


     
Company Name:CURIS
Stock Ticker (Symbol):CRIS
Traded Exchange:NASDAQ Stock Exchange
Average Traded Price:$2.63
Average Daily Traded Volume:638,100
Started to Trade on:Friday, July 01, 2011

CURIS Profile

Curis, Inc., a drug discovery and development company, focuses on the research and development of cancer therapeutics. The company, under collaboration with Genentech, Inc., is conducting a pivotal Phase II clinical trial on its lead molecule, GDC-0449 in advanced basal cell carcinoma patients, as well as various Phase II clinical trials in first-line metastatic colorectal cancer and advanced ovarian cancer patients. It is also evaluating CUDC-101, a small molecule that is in a Phase I clinical testing and is designed to target histone deacetylase, epidermal growth factor receptor, and epidermal growth factor receptor 2. In addition, Curis has a development candidate, Debio 0932, which is a Heat Shock Protein 90 or Hsp90 inhibitor. The company holds a license agreement with Debiopharm related to its Hsp90 technologies. Further, it involves in preclinical testing for the development of candidates from its targeted cancer programs. The company was founded in 2000 and is based in Lexington, Massachusetts.

Disclaimer | Privacy © 1997-2013 MarketVolume.com. All Rights Reserved. SV1
Charts
Stocks & ETFs
Indexes
Advance Decline
Knowledge Base
Trading Systems
News

© 1997-2014 www.MarketVolume.com. All Rights Reserved.